Start-Up Spotlight: Sight Diagnostics’ Imaging Technology Allows Accurate Diagnostics With Small Blood Samples

19 Dec 2019

The US FDA recently cleared Sight’s Olo analyzer to run complete blood counts on samples as small as two drops. The company is currently marketing Olo to hospital labs in the US but hopes to eventually earn a CLIA waiver so Olo can be marketed to smaller physician practices and pharmacies and used for other common blood-based diagnostics.

Sight Diagnostics is applying machine learning and computer vision analysis to in vitro diagnostics to create blood tests that are less invasive for the patient and more cost-effective for the health system.

Sight’s analyzers capture about 1,000 highly detailed microscopic images of a blood sample and then interpret the images with proprietary...